OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44
Annika Niehrs, Wilfredo F. García-Beltrán, Paul J. Norman, et al.
Nature Immunology (2019) Vol. 20, Iss. 9, pp. 1129-1137
Open Access | Times Cited: 74
Annika Niehrs, Wilfredo F. García-Beltrán, Paul J. Norman, et al.
Nature Immunology (2019) Vol. 20, Iss. 9, pp. 1129-1137
Open Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
NK cells for cancer immunotherapy
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 959
Noriko Shimasaki, Amit Jain, Dario Campana
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 3, pp. 200-218
Closed Access | Times Cited: 959
ANCA-associated vasculitis
A. Richard Kitching, Hans‐Joachim Anders, Neil Basu, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 676
A. Richard Kitching, Hans‐Joachim Anders, Neil Basu, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 676
The cancer–natural killer cell immunity cycle
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 442
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 442
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Natalie K. Wolf, Djem Kissiov, David H. Raulet
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 90-105
Closed Access | Times Cited: 299
Natalie K. Wolf, Djem Kissiov, David H. Raulet
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 90-105
Closed Access | Times Cited: 299
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
Cell (2021) Vol. 185, Iss. 4, pp. 603-613.e15
Open Access | Times Cited: 252
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
Cell (2021) Vol. 185, Iss. 4, pp. 603-613.e15
Open Access | Times Cited: 252
Natural-Killer-Cell-Inspired Nanorobots with Aggregation-Induced Emission Characteristics for Near-Infrared-II Fluorescence-Guided Glioma Theranostics
Guanjun Deng, Xinghua Peng, Zhihong Sun, et al.
ACS Nano (2020) Vol. 14, Iss. 9, pp. 11452-11462
Closed Access | Times Cited: 208
Guanjun Deng, Xinghua Peng, Zhihong Sun, et al.
ACS Nano (2020) Vol. 14, Iss. 9, pp. 11452-11462
Closed Access | Times Cited: 208
NK cells and ILCs in tumor immunotherapy
Simona Sivori, Daniela Pende, Linda Quatrini, et al.
Molecular Aspects of Medicine (2020) Vol. 80, pp. 100870-100870
Open Access | Times Cited: 191
Simona Sivori, Daniela Pende, Linda Quatrini, et al.
Molecular Aspects of Medicine (2020) Vol. 80, pp. 100870-100870
Open Access | Times Cited: 191
Advances of medical nanorobots for future cancer treatments
Xiangyi Kong, Peng Gao, Jing Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 101
Xiangyi Kong, Peng Gao, Jing Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 101
Research Progress on NK Cell Receptors and Their Signaling Pathways
Yingying Chen, Dan Lu, Alexey V. Churov, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 81
Yingying Chen, Dan Lu, Alexey V. Churov, et al.
Mediators of Inflammation (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 81
Natural Killer Cell-Based Immunotherapy against Glioblastoma
Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Maeoka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2111-2111
Open Access | Times Cited: 23
Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Maeoka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2111-2111
Open Access | Times Cited: 23
NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells
Benedetta Padoan, Christian Casar, Jenny Krause, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114089-114089
Open Access | Times Cited: 8
Benedetta Padoan, Christian Casar, Jenny Krause, et al.
Cell Reports (2024) Vol. 43, Iss. 4, pp. 114089-114089
Open Access | Times Cited: 8
NK Cell-Based Immunotherapy for Hematological Malignancies
Simona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 10, pp. 1702-1702
Open Access | Times Cited: 63
Simona Sivori, Raffaella Meazza, Concetta Quintarelli, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 10, pp. 1702-1702
Open Access | Times Cited: 63
Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity
Stephanie Burnell, Lorenzo Capitani, Bruce J. MacLachlan, et al.
Immunotherapy Advances (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 44
Stephanie Burnell, Lorenzo Capitani, Bruce J. MacLachlan, et al.
Immunotherapy Advances (2021) Vol. 2, Iss. 1
Open Access | Times Cited: 44
Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Natalia Colomar‐Carando, Laurent Gauthier, Pietro Merli, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 3, pp. 291-302
Open Access | Times Cited: 28
Natalia Colomar‐Carando, Laurent Gauthier, Pietro Merli, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 3, pp. 291-302
Open Access | Times Cited: 28
Innate receptors with high specificity for HLA class I–peptide complexes
Malcolm J. W. Sim, Paul Brennan, Katherine L. Wahl, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 16
Malcolm J. W. Sim, Paul Brennan, Katherine L. Wahl, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 16
The role of natural killer cells in liver inflammation
Andrew J. Highton, Iona S. Schuster, Mariapia A. Degli‐Esposti, et al.
Seminars in Immunopathology (2021) Vol. 43, Iss. 4, pp. 519-533
Open Access | Times Cited: 38
Andrew J. Highton, Iona S. Schuster, Mariapia A. Degli‐Esposti, et al.
Seminars in Immunopathology (2021) Vol. 43, Iss. 4, pp. 519-533
Open Access | Times Cited: 38
The Role of NK Cells in EBV Infection and EBV-Associated NPC
Yi Tian Png, Audrey Zhi Yi Yang, Mei Ying Lee, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 300-300
Open Access | Times Cited: 35
Yi Tian Png, Audrey Zhi Yi Yang, Mei Ying Lee, et al.
Viruses (2021) Vol. 13, Iss. 2, pp. 300-300
Open Access | Times Cited: 35
NK Cell-Based Immunotherapy in Colorectal Cancer
Mariella Della Chiesa, Chiara Setti, Chiara Giordano, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1033-1033
Open Access | Times Cited: 25
Mariella Della Chiesa, Chiara Setti, Chiara Giordano, et al.
Vaccines (2022) Vol. 10, Iss. 7, pp. 1033-1033
Open Access | Times Cited: 25
Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia
Zonghan Wang, Wei Li, Hao Dong, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 13
Zonghan Wang, Wei Li, Hao Dong, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 13
Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors
Wen-Shang Liu, Lili Wu, Cui-Min Chen, et al.
Materials Today Bio (2023) Vol. 22, pp. 100751-100751
Open Access | Times Cited: 13
Wen-Shang Liu, Lili Wu, Cui-Min Chen, et al.
Materials Today Bio (2023) Vol. 22, pp. 100751-100751
Open Access | Times Cited: 13
Inhibitory and Activating Natural Killer Receptors in Humans: A Historical Overview
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
Springer eBooks (2025), pp. 1-51
Closed Access
Claudia Cantoni, Michela Falco, Massimo Vitale, et al.
Springer eBooks (2025), pp. 1-51
Closed Access
Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities
Joana R. Lérias, Eric de Sousa, Georgia Paraschoudi, et al.
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 35
Joana R. Lérias, Eric de Sousa, Georgia Paraschoudi, et al.
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 35
SARS-CoV-2 mRNA vaccination elicits robust and persistent T follicular helper cell response in humans
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 30
Philip A. Mudd, Anastasia A. Minervina, Mikhail V. Pogorelyy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 30
Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma
Amanda A. van Vliet, Anna‐Maria Georgoudaki, Monica Raimo, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4722-4722
Open Access | Times Cited: 29
Amanda A. van Vliet, Anna‐Maria Georgoudaki, Monica Raimo, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4722-4722
Open Access | Times Cited: 29
A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer
Yuhan Sun, Alexander James Sedgwick, Md. Abdullah‐Al‐Kamran Khan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
Yuhan Sun, Alexander James Sedgwick, Md. Abdullah‐Al‐Kamran Khan, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
